Uncategorized

SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform

PR Newswire
By PR Newswire
1 Min Read

SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ — SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development,…

​SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ — SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development,…  ​All Consumer Technology

Share This Article
ByPR Newswire
PR Newswire is the storytelling engine behind thousands of corporate announcements worldwide. With a rich legacy in media distribution, it helps brands turn their updates into meaningful narratives by connecting them with journalists, investors, and audiences who shape global conversations. Through trusted networks and data-backed distribution, PR Newswire ensures every story reaches the people who matter most.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *